439 results on '"Wraith, David C"'
Search Results
2. Symptoms and risk factors for long COVID in non-hospitalized adults
3. Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice
4. Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy
5. Designing antigens for the prevention and treatment of autoimmune diseases
6. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
7. Negative Selection during the Peripheral Immune Response to Antigen
8. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
9. The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care
10. Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
11. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome
12. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
13. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation
14. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire
15. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice
16. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
17. Adaptive T cell tuning in immune regulation and immunotherapy of autoimmune diseases✰
18. A Role for Galanin in Human and Experimental Inflammatory Demyelination
19. Enhanced Selection of FoxP3⁺ T-Regulatory Cells Protects CTLA-4-Deficient Mice from CNS Autoimmune Disease
20. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
21. Antigen-specific immunotherapy of autoimmune and allergic diseases
22. In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
23. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength
24. Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics
25. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
26. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy
27. A Single Amino Acid Change in a Myelin Basic Protein Peptide Confers the Capacity to Prevent Rather than Induce Experimental Autoimmune Encephalomyelitis
28. Preclinical models of arthritis for studying immunotherapy and immune tolerance
29. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
30. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases
31. The adaptive immune system in diseases of the central nervous system
32. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
33. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases
34. Antigen and Checkpoint Receptor Recalibration of T Cell Receptor Signal Strength
35. 2 Are mesenchymal stem cells immune privileged?
36. Peptide allergen‐specific immunotherapy for allergic airway diseases— State of the art
37. A LAT-Based Signaling Complex in the Immunological Synapse as Determined with Live Cell Imaging is Less Stable in T Cells with Regulatory Capability
38. Vaccination and autoimmune disease: what is the evidence?
39. Peptide-based therapy for autoimmune diseases
40. IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE
41. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
42. Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and Duration
43. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
44. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
45. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
46. Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome
47. Chromatin Priming Renders T Cell Tolerance-Associated Genes Sensitive to Activation below the Signaling Threshold for Immune Response Genes
48. SARS-CoV-2 seroconversion in health care workers
49. Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis
50. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.